"One of the biggest problems we see, at least on the physician side, is that any other kind of disease that you have, you always get a quantitative test. So if you have heart disease or high cholesterol, you get that blood panel back with concrete numbers on it. and if it's diabetes, it might be A1C, it might be glucose, but for musculoskeletal disorders, it's always in either an x-ray or an MRI, which is considered qualitative"

We sit down with Rebecca Zheng, the mind behind Calcu, a groundbreaking company at the forefront of medical device technology for musculoskeletal disorders in this episode of Founders In LA.

We uncover the inspiration behind Calcu's inception, driven by Rebecca's personal battle with a herniated disc and subsequent journey into wearable technology during her time at Georgia Tech.

Calcu’s mission is to transform the diagnosis and treatment of conditions like sciatica and knee pain through smart, sensor-based devices, providing real-time, actionable data outside the clinical setting.

This episode peels back the layers on the challenges of healthcare entrepreneurship, the pivot from a consumer-focused model to a medical-oriented approach, and the future of wearable technology in enhancing patient care.

Join us as Rebecca shares insights on the importance of quantitative data in musculoskeletal disorders, the potential to reduce reliance on surgery and medications, and her vision for integrating Calcu into the healthcare ecosystem.